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NONVIRAL TRANSFER TECHNOLOGY BRIEF COMMUNICATION
Electrically mediated plasmid DNA delivery to
hepatocellular carcinomas in vivo
L Heller1, MJ Jaroszeski2, D Coppola3, C Pottinger2, R Gilbert4 and R Heller2
1Center for Molecular Delivery, University of South Florida; Departments of 2Surgery and 3Pathology, University of South Florida
College of Medicine; and 4College of Engineering, University of South Florida, Tampa, FL, USA
Gene therapy by direct delivery of plasmid DNA has several
advantages over viral gene transfer, but plasmid delivery is
less efficient. In vivo electroporation has been used to
enhance delivery of chemotherapeutic agents to tumors in
both animal and human studies. Recently, this delivery tech-
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Safe and efficient methods for in vivo DNA delivery at
diverse expression levels and durations are needed for
the effective treatment of a variety of diseases. Current
in vivo delivery methods can be broadly divided into viral
and nonviral categories. Although viral vectors induce
long-term, high gene expression, limitations such as the
possibility of insertional mutagenesis or induction of
the host immune response limit the usefulness of viral
delivery.1
Mouse skeletal muscle injected with plasmid DNA
alone results in long-term protein expression.2 Plasmid
DNA is neither replicated nor integrated into the host cell
genome, but remains in its episomal form3 and is
expressed in both dividing and nondividing cells. The
injection of DNA does not result in the production of
anti-DNA antibodies,4,5 which allows for multiple treat-
ments. The resulting expression may be short term com-
pared with viral delivery, which may be an advantage if
long-term expression is not desirable.
In all in vivo gene therapy techniques, reproducible
delivery and control of molecule dosage are common
problems. Since the efficiency of gene transfer by naked
DNA injection is lower than that of viral delivery, both
chemical and physical techniques have been used to
increase the efficiency of DNA uptake and expression. In
vivo liposome-mediated delivery of plasmid DNA was
first described in 19836 and is used in many clinical trials.
In particle bombardment or ‘gene gun’ transfer, the target
tissue is bombarded with DNA coated gold particles,
which penetrate the cells.7
Electroporation is a recently developed method using
electric pulses to enhance cellular uptake of extracellular
molecules. This technique has been used to deliver drugs
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nique has been extended to large molecules such as plas-
mid DNA. Here, the successful delivery of plasmids enco-
ding reporter genes to rat hepatocellular carcinomas by in
vivo electroporation is demonstrated. Gene Therapy (2000)
7, 826–829.
successfully to treat several types of tumors in both ani-
mal and human studies.8,9 Electrically enhanced in vivo
plasmid gene delivery to mouse skin cells was first dem-
onstrated in 199110 and is more effective than liposome
delivery or particle bombardment.11 This method has
recently been used to deliver reporter genes in vivo to
normal rat hepatocytes,12,13 rat brain tumor cells,14 mouse
testes,15 mouse melanoma cells,16 and skeletal muscle.17–19
A previous study by this laboratory demonstrated in
vivo gene delivery to normal liver tissue using electropor-
ation.12 In the present study, the delivery of plasmids
encoding reporter genes to a solid visceral tumor is dem-
onstrated. Reporter genes were used to evaluate delivery
of plasmid DNA to rat hepatocellular carcinomas. Since
these fast growing tumors reach a mean size of 345 mg
by 48 h after treatment, this time-point was used for these
experiments. In order initially to demonstrate the
enhancement of DNA delivery to these tumors by elec-
troporation, conditions similar to those previously
described for delivery of bleomycin to hepatocellular car-
cinomas with electroporation were used.8 This same puls-
ing protocol enhanced luciferase expression nine-fold
over plasmid DNA injection alone in normal liver
tissue.12 In rat hepatocellular carcinomas, the application
of a similar pulsing protocol resulted in a 15-fold increase
in luciferase activity over simple injection (Figure 1).
Thus for rat hepatocellular carcinomas, the same pulsing
protocol used to deliver chemotherapeutic agents effec-
tively enhanced plasmid DNA delivery in vivo.
Electroporation is a threshold phenomenon. The field
strength necessary for molecule delivery must exceed a
threshold value. Moderate increases in the applied field
strength result in delivery; however, larger increases in
the applied field from this threshold result in tissue dam-
age. With this constraint in mind, the effect of changes
in pulse field strength on gene delivery were explored
(Figure 2). These experiments revealed that pulses of
750 V/cm did not significantly increase luciferase
activity. However, 1000 and 1250 V/cm pulses induced
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Figure 1 Enhancement of plasmid DNA delivery to rat hepatocellular car-
cinomas as determined by luciferase expression. Male Sprague–Dawley
rats were placed in an induction chamber charged with 5% isoflurane in
O2. After anesthetization, rats were fitted with a standard rodent mask and
kept under general anesthesia with 3% isoflurane. The liver was surgically
exposed and injected with 106 N1S1 rat hepatoma cells (ATCC CRL1604)
in 50 ml PBS. Tumors were allowed to grow for 7 days. Following tumor
growth, the animals were anesthetized as above and the liver with tumors
surgically exposed. Tumors were measured using a digital caliper and
tumor volume calculated by the formula v = abcp/6, where a, b, and c are
the three mutually orthogonal diameters, yielding an average tumor vol-
ume of 80 mm3. pCMV-Luc+14 was prepared using Qiagen Megaprep kits
(Qiagen, Valencia, CA, USA), then diluted in sterile injectable saline.
Tumors were injected with 1 mg plasmid per mm3 tumor volume in an
injection volume equal to one half the tumor volume. Electric pulses were
applied at a field strength of 1250 V/cm immediately after injection using
a custom designed applicator containing seven electrodes, placed in three
parallel rows, spaced to allow strategic placement of the electrodes around
and into the tumor and a CytoPulse PA4000 DC Generator (CytoPulse
Sciences). A total of 14 pulses (100 ms, 1 Hz) were applied in a seven-
step sequence through the different electrodes. At each sequence step, the
field was moved around the tumor by activating 2, 3, or 4 of the seven
electrodes. Previous work had demonstrated that rotating a field was more
effective.22 After pulses, the animals were immediately closed with surgical
staples. Animals were humanely killed, 48 h after plasmid delivery and
the tumors were excised. For luciferase quantitation, the tumors were
weighed and then homogenized in buffer (50 mm K3PO4, 1 mm EDTA,
1 mm DTT, 10% glycerol) using a Tissumizer (Tekmar, Cincinnati, OH,
USA). Extracts were assayed for luciferase activity23 and quantitated
using a MLX microtiter plate luminometer (Dynex Technologies, Chan-
tilly, VA, USA). Activity was normalized to the tumor weight and
expressed relative to injection alone. Each bar represents the mean of three
independent experiments with three tumors treated per experiment, for a
total of nine tumors. Error bars are the standard error of the mean. Stat-
istical significance (P < 0.05) relative to injection alone is noted by an
asterisk.
a 14- to 16-fold increase in plasmid DNA expression over
injection alone. Peak expression levels (30-fold) were
observed when 1500 V/cm pulses were applied. At a
higher field strength, 2000 V/cm, higher luciferase
activity was observed, but visible tissue damage was
noted in the normal liver tissue in the form of a highly
localized avascular region immediately adjacent to the
electrode insertion points. No significant damage to nor-
mal tissue in response to 100 ms electric pulses is noted
at 1500 V/cm or less.20 Since high levels of expression
were observed at 1500 V/cm and no damage was noted,
ensuing experiments were performed at this voltage.
The in vivo electroporation experiments described thus
Gene Therapy
Figure 2 Effect of pulse field strength after administration of plasmid
DNA. Tumors were induced, injected with plasmid DNA followed by
pulses of varying field strength and analyzed for luciferase expression as
in Figure 1. Bars represent the mean and standard error of the mean from
four independent experiments, each containing three tumors per treatment
group, for a total of 12 tumors. Statistical significance (P < 0.05) relative
to injection alone is noted by an asterisk.
far were performed after the injection of 1 mg DNA per
mm3 tumor volume. This amount of DNA resulted in eas-
ily quantifiable luciferase expression. DNA dose depen-
dence was investigated in order to maximize tumor
reporter protein expression. Quantities ranging from 0.1
to 2 mg per mm3 tumor volume were examined
(Figure 3). Luciferase expression showed a DNA dose
dependence, with the highest tested activity at 2 mg per
mm3 tumor volume.
To determine the cellular distribution of delivery
within the tumor, histochemical staining for b-galacto-
sidase was performed (Figure 4a and b). Tumors treated
with both plasmid and electric fields were positive for
expression as indicated by the blue stained cells.
Figure 3 Dependence of luciferase expression on amount of plasmid DNA
injected. Tumors were injected with varying concentrations of plasmid
DNA in the same volume of saline normalized to tumor volume, followed
by pulses at 1500 V/cm. Luciferase activity was determined as described
in Figure 1. Bars represent the mean and standard error of the mean from
three independent experiments, each containing three tumors per treat-
ment group, for a total of nine tumors. Statistical significance (P < 0.05)
relative to injection alone is noted by an asterisk.
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Figure 4 (a, b) Histochemical staining for b-galactosidase expression in frozen sections. Tumors were induced in rats and injected with pSV-bGal
(Promega, Madison, WI, USA). After 48 h, animals were humanely killed and the tumors were excised and fixed in 0.5% glutaraldehyde. b-Galactosidase
activity was detected in 15 mm-thick cryosections by staining in 15 mm K4Fe(CN)6, 15 mm K3Fe(CN)6, 2 mm MgCl2, and 1 mg/ml X-gal in PBS for
12 h. (a) pSV-bGal injection only; (b) injection of pSV-bGal followed immediately by pulses at 1500 V/cm as described previously; (c,d) histologic
analysis of paraffin-embedded sections by hematoxylin and eosin (H&E) staining after 48 h from (c) a tumor that did not receive pulses, and (d) a tumor
which received the same electrical treatment as in (b). Unpulsed and pulsed tumors both revealed sheets of viable cells with increased nuclear to
cytoplasmic ratio, pleomorphic nuclei with prominent eosinophilic nucleoli, and numerous mitotic figures. Rare single apoptotic cells were identified,
and there was no necrosis present.
Expression was noted only in the area that received elec-
troporation. No expression was noted in tumors that
received plasmid injection only or no treatment. Examin-
ation of hematoxylin and eosin stained sections from
tumors that were unpulsed and pulsed (Figure 4c and d)
revealed viable tumor cells with no evidence of necrosis
and minimal single cell apoptosis for both types of
samples. This confirmed that electrical pulses alone
caused no significant damage to the tumor tissue.
These data corroborate previous studies that short
length (ms) pulses efficiently enhance delivery of DNA to
tissues such as normal hepatocytes12 and rat brain tumor
cells.14 Longer length (ms) pulses also result in increased
expression of injected plasmids to mouse testes,15 rat
hepatocytes,13 mouse melanoma cells16 and mouse skel-
etal muscle,17–19 but tissue damage is observed at field
strengths greater than 100 V/cm.13,15
The results presented here demonstrate that in vivo
electroporation enhances delivery of plasmid DNA to rat
hepatocellular carcinomas. This delivery technique could
eventually be adapted for clinical studies by performing
the molecular delivery using laparotomy. Detectable lev-
els of non-reporter cDNA expression have been reached
after augmentation of intratumor plasmid DNA delivery
by in vivo electroporation. Transfer of plasmid DNA by
electroporation of a plasmid encoding monocyte
chemoattractant protein 1 into rat brain tumors resulted
in increased numbers of tumor monocytes.14 Electropor-
ation of a plasmid encoding a Stat3 dominant negative
variant into pre-existing mouse melanomas inhibited
tumor growth and induced tumor regression.21 Thera-
peutic levels have also been reached after electroporation
of healthy tissue. Erythropoietin cDNA expression after
muscle injection was increased to levels adequate to
induce an increase in hematocrit in mice.19 An increase
in IL-5 protein expression was observed after muscle
electroporation.17 It is apparent that protein expression
observed after in vivo electroporation is ample to induce
quantifiable responses in vivo. One major benefit of this
technique is that protein expression is focused on the area
electroporated. In tissues other than muscle, plasmid
delivery, even enhanced, may turn out to result in only
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long-term expression of a molecule such as an immune
inducer would be toxic. Electroporation offers a highly
reproducible method of in vivo plasmid delivery which
is a complement to liposome and gene gun delivery and
an alternative to viral delivery.
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